{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:17:30Z","timestamp":1775265450645,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.nmd.2011.06.751","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T04:25:42Z","timestamp":1314591942000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Acetylcholine receptor antibodies in patients with genetic myopathies: Clinical and biological significance"],"prefix":"10.1016","volume":"22","author":[{"given":"Russell J.M.","family":"Lane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis G.","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2011.06.751_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2008-1052426","article-title":"The coexistence of myasthenia gravis and myotonic dystrophy in one family","volume":"18","author":"Maytal","year":"1987","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2011.06.751_b0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archneur.1989.00520370103030","article-title":"Concurrence of limb girdle muscular dystrophy and myasthenia gravis","volume":"46","author":"Husain","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0015","first-page":"179","article-title":"A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis","volume":"41","author":"Sakuma","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nmd.2011.06.751_b0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/PL00007868","article-title":"Facioscapulohumeral muscular dystrophy and myasthenia gravis co-existing in the same patient: a case report","volume":"249","author":"McGonigal","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.20118","article-title":"Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis","volume":"30","author":"Sansone","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.06.751_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNO.0b013e31803312fa","article-title":"Mitochondrial ophthalmoplegia with fatigable weakness and elevated acetylcholine receptor antibody","volume":"27","author":"Behbehani","year":"2007","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"10.1016\/j.nmd.2011.06.751_b0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pediatrneurol.2007.01.014","article-title":"Myotonic dystrophy in a female with myasthenia gravis","volume":"36","author":"De Los Angeles","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mus.21046","article-title":"Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma","volume":"38","author":"Feyma","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.06.751_b0045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PloS Medicine"},{"key":"10.1016\/j.nmd.2011.06.751_b0050","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2009.11.016","article-title":"Autoinflammation: the prominent role of IL-1 in monogenic autoimmune diseases and implications for common illnesses","volume":"124","author":"Goldbach-Mansky","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nmd.2011.06.751_b0055","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Path"},{"key":"10.1016\/j.nmd.2011.06.751_b0060","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.nmd.2009.07.016","article-title":"Myasthenia gravis precipitated by trauma: latent myasthenia and the concept of \u2018threshold\u2019","volume":"19","author":"Lane","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2011.06.751_b0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and function of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.nmd.2011.06.751_b0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"UK myasthenia gravis survey. Evidence of under diagnosis of myasthenia gravis in older people","volume":"74","author":"Vincent","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2011.06.751_b0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000179948.65895.1a","article-title":"Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis","volume":"17","author":"Tidball","year":"2005","journal-title":"Clin Opin Rheumatol"},{"key":"10.1016\/j.nmd.2011.06.751_b0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mus.21156","article-title":"Correlating extent of neuromuscular instability with acetylcholine receptor antibodies","volume":"39","author":"Farrugia","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.06.751_b0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2011.06.751_b0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/WNL.31.2.220","article-title":"No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis","volume":"31","author":"Roses","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2011.06.751_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/205873929901200303","article-title":"Myasthenia gravis: correlation of age with clinical course and anti-AChr antibody levels","volume":"12","author":"Kapinas","year":"1999","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.nmd.2011.06.751_b0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2249.1992.tb02982.x","article-title":"Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy","volume":"87","author":"Kuks","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nmd.2011.06.751_b0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.57.4.733","article-title":"Tongue atrophy in facioscapulohumeral muscular dystrophy","volume":"57","author":"Yamanaka","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2011.06.751_b0110","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/01.wnl.0000219760.76441.f8","article-title":"Dysphagia in facioscapulohumeral muscular dystrophy","volume":"66","author":"Wohlgemuth","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2011.06.751_b0115","first-page":"101","article-title":"Effect of thymectomy in immune diseases other than myasthenia","volume":"42","author":"Szobor","year":"1985","journal-title":"Acta Med Hung"},{"key":"10.1016\/j.nmd.2011.06.751_b0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(84)91019-5","article-title":"Thymectomy in polymyositis","author":"Lane","year":"1984","journal-title":"Lancet I"},{"key":"10.1016\/j.nmd.2011.06.751_b0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mus.880120514","article-title":"Thymectomy in refractory dermatomyositis","volume":"12","author":"Cumming","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.06.751_b0130","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2169\/internalmedicine.39.1108","article-title":"Rapidly progressive polymyositis with elevated antiacetylcholine receptor antibody activity","volume":"39","author":"Yamaguchi","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.nmd.2011.06.751_b0135","first-page":"312","article-title":"Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody","volume":"36","author":"Kuyama","year":"1997","journal-title":"Inten Med"},{"key":"10.1016\/j.nmd.2011.06.751_b0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0145","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2011.06.751_b0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2011.06.751_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2009.12.036","article-title":"AIRE, master of many trades","volume":"140","author":"Kyewski","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2011.06.751_b0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1196\/annals.1405.026","article-title":"How promiscuity promotes tolerance. The case of myasthenia gravis","volume":"1132","author":"Kyewski","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nmd.2011.06.751_b0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1994.1039","article-title":"Evaluation of myosin-reactive antibodies from a panel of myasthenia gravis patients","volume":"70","author":"Mohan","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.nmd.2011.06.751_b0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1749-6632.1998.tb10978.x","article-title":"Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma","volume":"841","author":"Baggi","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2011.06.751_b0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2011.06.751_b0185","first-page":"14","article-title":"Myasthenia gravis autoantibodies have a target also outside the neuromuscular junction","volume":"11","author":"Gilhus","year":"2011","journal-title":"ANCR"},{"key":"10.1016\/j.nmd.2011.06.751_b0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00002371-200207000-00009","article-title":"Induction of myasthenia gravis, myositis and insulin dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer","volume":"25","author":"Fraenkel","year":"2002","journal-title":"J Immunother"},{"key":"10.1016\/j.nmd.2011.06.751_b0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s002280050143","article-title":"Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma","volume":"50","author":"Rohde","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nmd.2011.06.751_b0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils or blocking TNF alpha function with etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2011.06.751_b0205","first-page":"1","article-title":"Circulating autoantibodies to troponin I in Emery\u2013Dreifuss muscular dystrophy","volume":"27","author":"Niebroj-Dobosz","year":"2008","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2011.06.751_b0210","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nmd.2011.06.751_b0215","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/BOR.0b013e328331638a","article-title":"Pathogenic mechanisms of disease in myositis:autoantigens as clues","volume":"21","author":"Betteridge","year":"2009","journal-title":"Curr Opinion Rheum"},{"key":"10.1016\/j.nmd.2011.06.751_b0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1096\/fj.05-4342fje","article-title":"Expression of toll-like receptors by human muscle cells in vitro and in vivo: TRL3 is highly expressed in inflammatory and HIV myopathies, mediated IL-8 release and up-regulation of NKG2D-ligands","volume":"20","author":"Schreiner","year":"2006","journal-title":"FASEB J"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896611009217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896611009217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:59:25Z","timestamp":1760774365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896611009217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0960896611009217"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2011.06.751","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylcholine receptor antibodies in patients with genetic myopathies: Clinical and biological significance","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2011.06.751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}